These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27789187)

  • 1. Validation study of the Medication Adherence Rating Scale. Results from the FACE-SZ national dataset.
    Fond G; Boyer L; Boucekine M; Aden LA; Schürhoff F; Tessier A; Andrianarisoa M; Berna F; Brunel L; Capdevielle D; Chereau I; Mallet J; Denizot H; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Rey R; Richieri R; Passerieux C; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Misdrahi D;
    Schizophr Res; 2017 Apr; 182():84-89. PubMed ID: 27789187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Medication Adherence Rating Scale in homeless patients with schizophrenia: Results from the French Housing First experience.
    Zemmour K; Tinland A; Boucekine M; Girard V; Loubière S; Resseguier N; Fond G; Auquier P; Boyer L;
    Sci Rep; 2016 Aug; 6():31598. PubMed ID: 27534796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability and validity of the Medication Adherence Rating Scale in a cohort of patients with schizophrenia from Nigeria.
    Owie GO; Olotu SO; James BO
    Trends Psychiatry Psychother; 2018; 40(2):85-92. PubMed ID: 29768528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A large-scale validation study of the Medication Adherence Rating Scale (MARS).
    Fialko L; Garety PA; Kuipers E; Dunn G; Bebbington PE; Fowler D; Freeman D
    Schizophr Res; 2008 Mar; 100(1-3):53-9. PubMed ID: 18083007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
    Byerly MJ; Nakonezny PA; Rush AJ
    Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric properties of the abbreviated version of the Scale to Assess Unawareness in Mental Disorder in schizophrenia.
    Michel P; Baumstarck K; Auquier P; Amador X; Dumas R; Fernandez J; Lancon C; Boyer L
    BMC Psychiatry; 2013 Sep; 13():229. PubMed ID: 24053640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of Adherence Profiles in Schizophrenia Using Self-Reported Adherence: Results From the FACE-SZ Dataset.
    Misdrahi D; Tessier A; Swendsen J; Berna F; Brunel L; Capdevielle D; Chereau I; Danion JM; De Pradier M; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Rey R; Richieri R; Passerieux C; Schandrin A; Schurhoff F; Tronche AM; Urbach M; Llorca PM; Fond G;
    J Clin Psychiatry; 2016 Sep; 77(9):e1130-e1136. PubMed ID: 27780318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
    Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
    Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects and side effects of antipsychotic treatment in schizophrenia: pros and cons of available self-rating scales.
    Wolters HA; Knegtering H; van den Bosch RJ; Wiersma D
    Schizophr Res; 2009 Jul; 112(1-3):114-8. PubMed ID: 19395241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing beliefs and attitudes towards antipsychotic medication from a recovery-based perspective: Psychometric properties of a new scale.
    Martins MJRV; Pinto AM; Castilho P; Macedo AF; Pereira AT; Bajouco M; Leite R; Matos O; Morais S; Madeira N; Nogueira V; Roque C; Santos P; Santos T; Santos T; Santos V; Troia AF; Barreto-Carvalho C
    Psychiatry Res; 2019 Mar; 273():325-330. PubMed ID: 30677722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric evaluation of medication adherence rating scale (MARS) among Nigerian patients with schizophrenia.
    Sowunmi OA; Onifade PO
    Niger J Clin Pract; 2019 Sep; 22(9):1281-1285. PubMed ID: 31489867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do patients with schizophrenia distinguish between attitudes toward antipsychotic medication and pharmacotherapy in general? Validation of the Beliefs About Medication Questionnaire.
    Beck EM; Vögelin R; Wirtz M; Cavelti M; Kvrgic S; Vauth R
    J Nerv Ment Dis; 2012 Jan; 200(1):33-43. PubMed ID: 22210360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-reported adherence by MARS-CZ reflects LDL cholesterol goal achievement among statin users: validation study in the Czech Republic.
    Ladova K; Matoulkova P; Zadak Z; Macek K; Vyroubal P; Vlcek J; Morisky DE
    J Eval Clin Pract; 2014 Oct; 20(5):671-7. PubMed ID: 24917035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication.
    Beck EM; Cavelti M; Kvrgic S; Kleim B; Vauth R
    Schizophr Res; 2011 Oct; 132(1):42-9. PubMed ID: 21820875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Validation of the Temporal Experience of Pleasure Scale (TEPS) in a French-speaking environment].
    Favrod J; Ernst F; Giuliani F; Bonsack C
    Encephale; 2009 Jun; 35(3):241-8. PubMed ID: 19540410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug compliance and health locus of control in schizophrenia].
    Combes C; Feral F
    Encephale; 2011 May; 37 Suppl 1():S11-8. PubMed ID: 21600328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [French adaptation and validation of the scale to assess unawareness of mental disorder].
    Raffard S; Trouillet R; Capdevielle D; Gely-Nargeot MC; Bayard S; Larøi F; Boulenger JP
    Can J Psychiatry; 2010 Aug; 55(8):523-31. PubMed ID: 20723280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.